Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ · Healthcare
Corbus Pharmaceuticals Holdings, Inc. Shareholder Equity 2015–2022
Corbus Pharmaceuticals Holdings, Inc. annual shareholder equity history from 2015 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Corbus Pharmaceuticals Holdings, Inc. shareholder equity as of December 31, 2022: 33.0M, a 52.26% decrease year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. shareholder equity for 2022 were 33.0M, a 52.26% decrease from 2021.
- Corbus Pharmaceuticals Holdings, Inc. shareholder equity for 2021 were 69.1M, a 52.64% increase from 2020.
- Corbus Pharmaceuticals Holdings, Inc. shareholder equity for 2020 were 45.3M, a 635.27% increase from 2019.
- Corbus Pharmaceuticals Holdings, Inc. shareholder equity for 2019 were 6.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Corbus Pharmaceuticals Holdings, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $33 |
| 2021 | $69 |
| 2020 | $45 |
| 2019 | $6 |
| 2018 | $28 |
| 2017 | $58 |
| 2016 | $9 |
| 2015 | $9 |
Corbus Pharmaceuticals Holdings, Inc. Shareholder Equity — FAQ
Corbus Pharmaceuticals Holdings, Inc. (CRBP) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBP's shareholder equity history?
The chart and table above show Corbus Pharmaceuticals Holdings, Inc.'s shareholder equity by year and by quarter, including the growth rate.